Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BELDEN INC.BDC · Entity 4002 | SVP, Bus. Dev. & Strategy | February 28, 2019 | March 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BELDEN INC.
Report date February 28, 2019 · Filed March 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,222 |
Reported balance
After 2019-02-28 transaction · row 1
1 source rowRow 1 · 2019-02-28 · Grant · Acquired 1,930 · Balance 8,222 F1: Represents a grant of RSUs granted by the Company's Compensation Committee on February 28, 2019. The RSUs will vest on February 28, 2022. Additional terms apply in the event of the holder's termination, death, disability or retirement. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $61.79 · Expires 2029-02-28 | Direct | 5,224 |
Reported balance
After 2019-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-28 · Grant · Acquired 5,224 · Balance 5,224 F2: The Stock Appreciation Rights (SARs) were issued at the closing price of the Company's stock on February 28, 2019 ($61.79). They will vest in equal amounts over three years and will expire ten years after the grant date. Upon exercise, the holder will receive in Belden stock the excess of fair market value per share at the time of exercise over the exercise price, times the number of SARs being exercised (after tax withholding, if applicable). Additional terms apply in the event of the holder's termination, death, disability or retirement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of RSUs granted by the Company's Compensation Committee on February 28, 2019. The RSUs will vest on February 28, 2022. Additional terms apply in the event of the holder's termination, death, disability or retirement.
F2: The Stock Appreciation Rights (SARs) were issued at the closing price of the Company's stock on February 28, 2019 ($61.79). They will vest in equal amounts over three years and will expire ten years after the grant date. Upon exercise, the holder will receive in Belden stock the excess of fair market value per share at the time of exercise over the exercise price, times the number of SARs being exercised (after tax withholding, if applicable). Additional terms apply in the event of the holder's termination, death, disability or retirement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2019 Filed Mar 5, 2019 23:26 UTC | BELDEN INC. BDC · Entity 4002 | GrantStock Appreciation Rights · Derivative | 5,224 | $0.00 Strike: $61.79 | $0.00 |
DisclosureSEC source: 0001209191-19-016962 · doc4.xml · derivative · entry 2 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,224 Underlying: Common Stock · 5,224 shares Expires 2029-02-28 F2 · shares: The Stock Appreciation Rights (SARs) were issued at the closing price of the Company's stock on February 28, 2019 ($61.79). They will vest in equal amounts over three years and will expire ten years after the grant date. Upon exercise, the holder will receive in Belden stock the excess of fair market value per share at the time of exercise over the exercise price, times the number of SARs being exercised (after tax withholding, if applicable). Additional terms apply in the event of the holder's termination, death, disability or retirement. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 23:26 UTC | BELDEN INC. BDC · Entity 4002 | GrantCommon Stock | 1,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016962 · doc4.xml · nonDerivative · entry 1 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,222 F1 · shares: Represents a grant of RSUs granted by the Company's Compensation Committee on February 28, 2019. The RSUs will vest on February 28, 2022. Additional terms apply in the event of the holder's termination, death, disability or retirement. Read SEC document |
| February 25, 2019 Filed Feb 26, 2019 20:47 UTC | BELDEN INC. BDC · Entity 4002 | GrantCommon Stock | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013433 · doc4.xml · nonDerivative · entry 1 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,292 F1 · shares: Shares awarded pursuant to the fulfillment of performance share units awarded on February 24, 2016, net of withholding taxes. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 16:19 UTC | BELDEN INC. BDC · Entity 4002 | GrantStock Appreciation Rights · Derivative | 8,890 | $0.00 Strike: $72.73 | $0.00 |
DisclosureSEC source: 0001209191-18-015380 · doc4.xml · derivative · entry 2 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,890 Underlying: Common Stock · 8,890 shares Expires 2028-02-28 F2 · security: The Stock Appreciation Rights (SARs) were issued at the closing price of the Company's stock on February 28, 2018 ($72.73). They will vest in equal amounts over three years and will expire ten years after the grant date. Upon exercise, the holder will receive in Belden stock the excess of fair market value per share at the time of exercise over the exercise price, times the number of SARs being exercised (after tax withholding, if applicable). Additional terms apply in the event of the holder's termination, death, disability or retirement. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 16:19 UTC | BELDEN INC. BDC · Entity 4002 | SaleCommon Stock | 550 | $74.62 | $41,041.00 |
DisclosureSEC source: 0001209191-18-015380 · doc4.xml · nonDerivative · entry 1 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,329 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Rosenberg on September 15, 2017. Read SEC document |
| February 27, 2018 Filed Feb 27, 2018 22:12 UTC | BELDEN INC. BDC · Entity 4002 | Exercise / conversionStock Appreciation Rights · Derivative | 2,477 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-18-014006 · doc4.xml · derivative · entry 4 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,477 shares Expires 2023-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Rosenberg on September 15, 2017. Read SEC document |
| February 27, 2018 Filed Feb 27, 2018 22:12 UTC | BELDEN INC. BDC · Entity 4002 | Disposition to issuerCommon Stock | 1,927 | $75.00 | $144,525.00 |
DisclosureSEC source: 0001209191-18-014006 · doc4.xml · nonDerivative · entry 3 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879 F3 · shares: This represents the difference between the number of SARs exercised (2,477) and the number of shares issued as a result of the exercise (550). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($75.00) and the exercise price ($50.01). Additional shares are then withheld to satisfy the Company's tax withholding obligations. Read SEC document |
| February 27, 2018 Filed Feb 27, 2018 22:12 UTC | BELDEN INC. BDC · Entity 4002 | Exercise / conversionCommon Stock | 2,477 | $50.01 | $123,874.77 |
DisclosureSEC source: 0001209191-18-014006 · doc4.xml · nonDerivative · entry 2 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Rosenberg on September 15, 2017. Read SEC document |
| February 27, 2018 Filed Feb 27, 2018 22:12 UTC | BELDEN INC. BDC · Entity 4002 | SaleCommon Stock | 779 | $75.00 | $58,425.00 |
DisclosureSEC source: 0001209191-18-014006 · doc4.xml · nonDerivative · entry 1 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,329 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Rosenberg on September 15, 2017. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 13:09 UTC | BELDEN INC. BDC · Entity 4002 | Tax withholdingCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-015572 · doc4.xml · nonDerivative · entry 1 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,108 F1 · shares: Shares withheld for tax purposes related to March 4, 2014 performance stock unit grant that vested on February 27, 2017. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 22:23 UTC | BELDEN INC. BDC · Entity 4002 | GrantStock Appreciation Rights · Derivative | 8,617 | $0.00 Strike: $74.91 | $0.00 |
DisclosureSEC source: 0001209191-17-014432 · doc4.xml · derivative · entry 1 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,617 Underlying: Common Stock · 8,617 shares Expires 2027-02-22 F1 · security: The Stock Appreciation Rights (SARs) were issued at the closing price of the Company's stock on February 22, 2017 ($74.91). They will vest in equal amounts over three years and will expire ten years after the grant date. Upon exercise, the holder will receive in Belden stock the excess of fair market value per share at the time of exercise over the exercise price, times the number of SARs being exercised (after tax withholding, if applicable). Additional terms apply in the event of the holder's termination, death, disability or retirement. Read SEC document |
| December 08, 2016 Filed Dec 9, 2016 21:13 UTC | BELDEN INC. BDC · Entity 4002 | SaleCommon Stock | 714 | $79.00 | $56,406.00 |
DisclosureSEC source: 0001209191-16-154386 · doc4.xml · nonDerivative · entry 1 Rosenberg Ross · CIK 0001608914 · SVP, Bus. Dev. & Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,889 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Rosenberg on December 17, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.